Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been
Filed Against AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)
OKLAHOMA CITY, OK -- (Marketwired) -- 05/12/13 -- On May 9, 2013, a
class action lawsuit was filed in the United States District Court
for the District of Massachusetts against AVEO Pharmaceuticals, Inc.
(NASDAQ: AVEO). The complaint alleges violations of federal
securities laws, Sections 10(b) and 20(a) of the Securities Exchange
Act of 1934 and Rule 10b-5, including allegations of issuing a series
of material or false misrepresentations to the market which had the
effect of artificially inflating the market price during the Class
Period, which is January 3, 2012 through May 1, 2013.
Plaintiff seeks to recover damages on behalf of all AVEO
Pharmaceuticals, Inc. shareholders who purchased common stock during
the Class Period and are therefore a member of the Class as described
above. If you are an investor with large losses, you may move the
Court no later than Monday, July 8, 2013 to serve as a lead plaintiff
for the entire Class. However, in order to do so, you must meet
certain legal requirements pursuant to the Private Securities
Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information or
participate in this or any other securities litigation, or should you
have any questions or concerns regarding this notice or preservation
of your rights, please contact:
K. Lynn Nunn
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: firstname.lastname@example.org
Or, visit the firm's website at www.federmanlaw.com
Press spacebar to pause and continue. Press esc to stop.